RESEARCH TRIANGLE PARK, N.C. (WTVD) -- Global biotechnology firm Biogen announced a major investment in its Research Triangle Park hub. The company said it will spend $2 billion to expand its North ...

In February 2025, Biogen Inc. (NASDAQ:BIIB) formed a partnership with Stoke Therapeutics to develop zorevunersen for Dravet ...

This was the stock's second consecutive day of losses.

Biogen Inc. has announced a $2 billion investment to expand its manufacturing capabilities at Research Triangle Park (RTP), ...

The biotech giant will grow its footprint at Research Triangle Park, while Premix opens a life sciences manufacturing plant ...

Biogen Inc. is investing $2 billion in its North Carolina RTP site, expanding manufacturing amid tariff talks.

Shares of biotech company Biogen (NASDAQ:BIIB) fell 3.1% in the morning session after analysts at Truist downgraded the stock ...

A higher-dose regimen of nusinersen may provide further benefits to people with SMA relative to the approved regimen, its ...

The drugmaker has invested $10 billion in Wake and Durham counties over the past 30 years. Biogen says that figure will ...

Biogen will invest an extra $2 billion to expand its RTP facilities, focusing on AI-driven manufacturing and late-stage ...

Biogen is investing $2 billion in its U.S. manufacturing footprint — but not in Massachusetts, where the drug company is ...